239 related articles for article (PubMed ID: 11958802)
1. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
[TBL] [Abstract][Full Text] [Related]
2. Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.
Fernández-Bello I; López-Longo FJ; Arias-Salgado EG; Jiménez-Yuste V; Butta NV
Orphanet J Rare Dis; 2013 May; 8():81. PubMed ID: 23711081
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic parameters in Behçet's disease: a reappraisal.
Koşar A; Oztürk M; Haznedaroğlu IC; Karaaslan Y
Rheumatol Int; 2002 May; 22(1):9-15. PubMed ID: 12120913
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Dysfunction and Altered Coagulation As Mediators of Thromboembolism in Behçet Disease.
Butta NV; Fernández-Bello I; López-Longo FJ; Jiménez-Yuste V
Semin Thromb Hemost; 2015 Sep; 41(6):621-8. PubMed ID: 26276934
[TBL] [Abstract][Full Text] [Related]
5. [Subclinical pro-thrombotic state in a relapse of Behcet's disease--case report].
Undas A; Pinis G
Pol Arch Med Wewn; 1996 Sep; 96(3):258-62. PubMed ID: 9122017
[TBL] [Abstract][Full Text] [Related]
6. Impaired haemostatic kinetics and endothelial function in Behçet's disease.
Haznedaroglu IC; Ozcebe OI; Ozdemir O; Celik I; Dündar SV; Kirazli S
J Intern Med; 1996 Oct; 240(4):181-7. PubMed ID: 8918508
[TBL] [Abstract][Full Text] [Related]
7. Decreased protein Z concentrations complicating the hypercoagulable state of Behçet's disease.
Oztürk MA; Ozbalkan Z; Onat AM; Ertenli I; Kiraz S; Aytemir K; Ureten K; Abali G; Calgüneri M; Kirazli S; Haznedaroglu IC
Clin Appl Thromb Hemost; 2003 Jul; 9(3):259-63. PubMed ID: 14507116
[TBL] [Abstract][Full Text] [Related]
8. Cardiac and great vessel thrombosis in Behçet's disease.
Ozatli D; Kav T; Haznedaroglu IC; Büyükaşik Y; Koşar A; Ozcebe O; Dündar SV
Intern Med; 2001 Jan; 40(1):68-72. PubMed ID: 11201375
[TBL] [Abstract][Full Text] [Related]
9. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
[TBL] [Abstract][Full Text] [Related]
10. Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
Lee YJ; Kang SW; Yang JI; Choi YM; Sheen D; Lee EB; Choi SW; Song YW
Thromb Res; 2002 Apr; 106(1):19-24. PubMed ID: 12165284
[TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction and deep venous thrombosis in a young patient with Behçet disease.
Calgüneri M; Aydemir K; Oztürk MA; Haznedaroğlu IC; Kiraz S; Ertenli I
Clin Appl Thromb Hemost; 2006 Jan; 12(1):105-9. PubMed ID: 16444444
[TBL] [Abstract][Full Text] [Related]
12. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
13. Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease.
Le Joncour A; Martos R; Loyau S; Lelay N; Dossier A; Cazes A; Fouret P; Domont F; Papo T; Jandrot-Perrus M; Bouton MC; Cacoub P; Ajzenberg N; Saadoun D; Boulaftali Y
Ann Rheum Dis; 2019 Sep; 78(9):1274-1282. PubMed ID: 31147357
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Probst K; Fijnheer R; Rothova A
Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
[TBL] [Abstract][Full Text] [Related]
15. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte deformability does not seem to be altered in Behçet's disease.
Simó M; Ricart JM; Santaolaria M; Ortí G; Vayá A
Clin Hemorheol Microcirc; 2007; 36(1):83-8. PubMed ID: 17211064
[TBL] [Abstract][Full Text] [Related]
17. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
Atıl A; Deniz A
Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
[TBL] [Abstract][Full Text] [Related]
18. The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behçet's disease.
Cosan F; Oku B; Gedar Totuk OM; Abaci N; Ustek D; Diz Kucukkaya R; Gul A
Int J Rheum Dis; 2018 Dec; 21(12):2175-2179. PubMed ID: 28809090
[TBL] [Abstract][Full Text] [Related]
19. The role of hemostatic mechanisms in the development of thrombosis in Behcet's disease: an analysis by modified rotation thromboelastogram (ROTEM).
Yaşar Bilge NŞ; Akay OM; Kaşifoğlu T; Kuş G; Korkmaz C
Clin Rheumatol; 2013 Dec; 32(12):1815-8. PubMed ID: 23975360
[TBL] [Abstract][Full Text] [Related]
20. Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis.
Kara Kivanc B; Gönüllü E; Akay OM; Ertürk A; Bal C; Cansu DÜ; Korkmaz C
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):63-67. PubMed ID: 29998845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
